Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Glossary Glossary

Combivir (AZT/3TC)

The Details

Combivir (zidovudine/lamivudine or AZT/3TC) is a nucleoside reverse transcriptase inhibitor used to treat HIV/AIDS. It is approved by the U.S. FDA for the treatment of HIV infection in adults and adolescents weighing 30 kg or more. It is listed in the HHS HIV treatment guidelines as part of an alternative regimen for people starting HIV treatment for the first time, when taken in combination with Edurant, Isentress, Kaletra, Lexiva/Norvir, Prezista/Norvir, Reyataz/Norvir or Sustiva.

Combivir

Adult single dose: Take one tablet twice daily. Each tablet contains 300 mg of zidovudine and 150 mg of lamivudine.

Restrictions:

  • Take Combivir with or without food.
  • Always take Combivir in combination with other anti-HIV medicines.
  • Women should not breastfeed while on Combivir.
The Basics
News
Research

  
  • Email Email
  • Glossary Glossary
Advertisement